Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mult Scler Relat Disord ; 71: 104515, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36736038

ABSTRACT

Relapsing-remitting multiple sclerosis (RRMS) is the most common clinical course of multiple sclerosis (MS), characterized by a chronic inflammatory state and elevated levels of oxidative markers. Food supplements with potential anti-inflammatory, antioxidant and neuroprotective effects have been tested as possible adjuvants in the treatment of MS. In this sense, this pilot study was carried out with the aim of verifying whether a minimum daily dose of a guarana, selenium and l-carnitine (GSC) based multi supplement, mixed in cappuccino-type coffee, administered for 12 weeks to 28 patients with RRMS could differentially modulate oxidative blood markers (lipoperoxidation, protein carbonylation and DNA oxidation) and inflammatory blood markers (protein levels of cytokines IL-1ß, IL-6, TNF-α, IFN-γ, IL-10, gene expression of these cytokines, and NLRP3 and CASP-1 molecules, and C-reactive protein levels). The results indicate that a low concentration of GSC is capable of decreasing the plasma levels of oxidized DNA and pro-inflammatory cytokines of RRMS patients. The results support further research into the action of GSC on clinical symptoms, not only in patients with MS, but also with other neurological conditions.


Subject(s)
Multiple Sclerosis, Relapsing-Remitting , Multiple Sclerosis , Paullinia , Selenium , Humans , Multiple Sclerosis, Relapsing-Remitting/diagnosis , Multiple Sclerosis/drug therapy , Selenium/therapeutic use , Coffee , Pilot Projects , Carnitine/therapeutic use , Nutrigenomics , Cytokines
SELECTION OF CITATIONS
SEARCH DETAIL
...